Literature DB >> 25728498

Birth order and risk of hepatocellular carcinoma in chronic carriers of hepatitis B virus: a case-control study in The Gambia.

Yusuke Shimakawa1,2,3, Maud Lemoine1,4, Christian Bottomley2, Harr Freeya Njai1, Gibril Ndow1,5, Abdoulie Jatta1, Saydiba Tamba1, Lamin Bojang1, Makie Taal6, Ousman Nyan7, Umberto D'Alessandro1,2, Ramou Njie1,5, Mark Thursz4, Andrew J Hall8.   

Abstract

BACKGROUND & AIMS: Early age at infection with Hepatitis B virus (HBV) increases the risk of chronic infection. Moreover, early HBV infection may further independently increase the risk of hepatocellular carcinoma (HCC) beyond its effect on chronicity.
METHODS: The distribution of birth order, a proxy for mode and timing of HBV transmission, was compared in The Gambia between hepatitis B surface antigen (HBsAg)-positive HCC cases recruited from hospitals (n = 72) and two HBsAg-positive control groups without HCC: population-based controls from a community HBV screening (n = 392) and hospital-based controls (n = 63).
RESULTS: HCC risk decreased with increasing birth order in the population-based case-control analysis. Using first birth order as the reference, the odds ratios were 0.52 (95% CI: 0.20-1.36), 0.52 (0.17-1.56), 0.57 (0.16-2.05) and 0.14 (0.03-0.64) for second, third, fourth and greater than fourth birth order respectively (P = 0.01). A similar inverse association was observed in the hospital-based case-control comparison (P = 0.04).
CONCLUSIONS: Compared to controls, HCC cases had earlier birth order, a proxy for young maternal age and maternal HBV viraemia at birth. This finding suggests that in chronic HBV carriers perinatal mother-to-infant transmission may increase HCC risk more than horizontal transmission. Providing HBV vaccine within 24 h of birth to interrupt perinatal transmission might reduce the incidence of HCC in The Gambia.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Africa; Hepatitis B; birth order; carcinoma; hepatocellular; infectious disease transmission; vertical

Mesh:

Substances:

Year:  2015        PMID: 25728498     DOI: 10.1111/liv.12814

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  10 in total

Review 1.  The Global Impact of Hepatitis B Vaccination on Hepatocellular Carcinoma.

Authors:  Joan Ericka Flores; Alexander J Thompson; Marno Ryan; Jessica Howell
Journal:  Vaccines (Basel)       Date:  2022-05-17

2.  Studied microRNA gene expression in human hepatocellular carcinoma by microRNA microarray techniques.

Authors:  Jian-Xiang Niu; Xing-Kai Meng; Jian-Jun Ren
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

Review 3.  Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma.

Authors:  Caecilia H C Sukowati; Korri E El-Khobar; Susan I Ie; Beatrice Anfuso; David H Muljono; Claudio Tiribelli
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 4.  Paediatric Virology and its interaction between basic science and clinical practice (Review).

Authors:  Ioannis N Mammas; Anne Greenough; Maria Theodoridou; Anna Kramvis; Maria Rusan; Angeliki Melidou; Paraskevi Korovessi; Georgia Papaioannou; Alexia Papatheodoropoulou; Chryssie Koutsaftiki; Maria Liston; George Sourvinos; Demetrios A Spandidos
Journal:  Int J Mol Med       Date:  2018-01-04       Impact factor: 4.101

5.  Prevention and care of hepatitis B in the rural region of Fatick in Senegal: a healthcare workers' perspective using a mixed methods approach.

Authors:  Tchadine Djaogol; Marion Coste; Fabienne Marcellin; Antoine Jaquet; Fanny Chabrol; Tamara Giles-Vernick; Aldiouma Diallo; Maria Patrizia Carrieri; Sylvie Boyer
Journal:  BMC Health Serv Res       Date:  2019-09-04       Impact factor: 2.655

6.  Hepatitis B virus preS2Δ38-55 variants: A newly identified risk factor for hepatocellular carcinoma.

Authors:  Damien Cohen; Sumantra Ghosh; Yusuke Shimakawa; Njie Ramou; Pierre Simon Garcia; Anaëlle Dubois; Clément Guillot; Nora Kakwata-Nkor Deluce; Valentin Tilloy; Geoffroy Durand; Catherine Voegele; Gibril Ndow; Umberto d'Alessandro; Céline Brochier-Armanet; Sophie Alain; Florence Le Calvez-Kelm; Janet Hall; Fabien Zoulim; Maimuna Mendy; Mark Thursz; Maud Lemoine; Isabelle Chemin
Journal:  JHEP Rep       Date:  2020-07-11

7.  The impact of the timely birth dose vaccine on the global elimination of hepatitis B.

Authors:  Margaret J de Villiers; Shevanthi Nayagam; Timothy B Hallett
Journal:  Nat Commun       Date:  2021-10-28       Impact factor: 14.919

8.  Screening for Hepatitis B in partners and children of women positive for surface antigen, Burkina Faso.

Authors:  Alice Nanelin Guingané; Rémi Kaboré; Yusuke Shimakawa; Eric Nagaonlé Somé; Dramane Kania; Amandine Pisoni; Nicolas Nagot; Rachel King; Roger Sombié; Nicolas Meda; Philippe Van de Perre; Edouard Tuaillon
Journal:  Bull World Health Organ       Date:  2022-02-22       Impact factor: 9.408

9.  The Costs of Introducing the Hepatitis B Birth Dose Vaccine into the National Immunization Programme in Senegal (NéoVac Study).

Authors:  Andréa Gosset; Marie Libérée Nishimwe; Mamadou Yaya Diallo; Lucas Deroo; Aldiouma Diallo; El Hadji Ba; Patrizia Maria Carrieri; Cheikh Sokhna; Muriel Vray; Yusuke Shimakawa; Sylvie Boyer
Journal:  Vaccines (Basel)       Date:  2021-05-18

10.  Prevalence and Clinical Significance of Occult Hepatitis B Infection in The Gambia, West Africa.

Authors:  Gibril Ndow; Amie Cessay; Damien Cohen; Yusuke Shimakawa; Mindy L Gore; Saydiba Tamba; Sumantra Ghosh; Bakary Sanneh; Ignatius Baldeh; Ramou Njie; Umberto D'Alessandro; Maimuna Mendy; Mark Thursz; Isabelle Chemin; Maud Lemoine
Journal:  J Infect Dis       Date:  2022-09-13       Impact factor: 7.759

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.